Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HIGH-DENSITY LIPOPROTEIN (HDL) - ANVISA Registration 81914040023

Access comprehensive regulatory information for HIGH-DENSITY LIPOPROTEIN (HDL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81914040023 and manufactured by OSANG HEALTHCARE CO., LTD.. The registration is held by UNA MEDIC IMPORTAÇAO E EXPORTAÇAO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including LABTEST DIAGNOSTICA S/A, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81914040023
Registration Details
ANVISA Registration Number: 81914040023
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

LipidPro Solução Controle de Colesterol - HDL
Risk Class II

Registration Details

81914040023

25351111111202396

32247380000150

Company Information

South Korea
PT: CORÉIA DO SUL

Dates and Status

Mar 13, 2023

VIGENTE

09/18/2025 19:00:01